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Early Periprosthetic Metastasis Following Total Hip 
Replacement in a Patient With Breast Carcinoma: 
A Case Report and Review of Literature
Ravi Badgea, b, Hiren Divechaa, David Socharta
Abstract
Early periprosthetic osteolysis following total hip replacement 
(THR) as a result of septic etiology has been well understood. 
Periprosthetic bone loss as a result of metastatic inﬁ  ltration is an 
uncommon and infrequent cause of early, progressive loosening 
of joint replacement prosthesis. Proximal femur has been the most 
common site of involvement compared to acetabular prosthesis. 
The rarity of this clinical entity can lead to delay in deﬁ  nitive diag-
nosis and management, thus affecting the ﬁ  nal outcome. Breast is 
the commonest site of carcinoma in female patients despite which 
not many cases of periprosthetic metastasis have been reported in 
the literature. We present the ﬁ  rst case of extensive, isolated periac-
etabular bone destruction following a THR in a 59 years old female 
patient with a history of breast carcinoma. Patients with known pri-
mary malignancy should be screened thoroughly before operation 
and should be followed regularly after joint replacement surgery to 
detect any metastatic foci around the prosthesis.
Keywords:  Periprosthetic metastasis; Total hip replacement; 
Breast carcinoma
Introduction
Total hip replacement (THR) is one of the most successful 
and cost-effective operations in restoring function and mo-
bility to patients with arthritis. Aseptic and septic loosening 
are signiﬁ  cant causes of its failure over time, but with the 
use of antibiotic prophylaxis and improvements in the bio-
mechanical properties and ﬁ  xation of implants, the longevity 
of THR has increased [1]. Periprosthetic bone loss due to 
metastatic inﬁ  ltration is uncommon but an important clinical 
entity, and can contribute to early periprosthetic loosening 
and failure.
Patients presenting with pain after a joint replacement 
are usually investigated to rule out any septic or aseptic eti-
ology and thus rare occurrence of metastatic inﬁ  ltration get 
overlooked and this may delay the appropriate management 
in such situations. Therefore it is essential to consider the 
possibility of metastatic involvement of the bone following 
joint replacement as one of the differential diagnosis and 
should be promptly investigated with the help of the multi-
disciplinary team.
Metastatic inﬁ  ltration around a THR is more commonly 
reported around femoral prosthesis compared to its acetabu-
lar counterpart. There has been only one case of acetabular 
involvement in a patient with gastric carcinoma which has 
been reported in English literature [2]. Although breast is 
the most common site of primary in female patients there is 
only one case report so far in the non-English literature with 
involvement of femoral component [3]. We present the ﬁ  rst 
case of early, extensive periacetabular bone loss following 
THR as a result of metastatic inﬁ  ltration in a patient with a 
history of breast carcinoma.
Case Report
A 59 years old female patient presented with bilateral hip os-
teoarthritis and underwent staged bilateral cemented THRs 
(right followed by left). The left hip replacement was per-
formed in August 2008 (Fig. 1). Intra-operative ﬁ  ndings dur-
ing both hip replacements were suggestive of osteoarthritis 
with no signs of metastasis. The patient made an unevent-
ful recovery after both procedures and was mobilizing well 
without any discomfort.
This patient had a history of a grade III invasive duc-
tal carcinoma (known to carry a favorable prognosis) of the 
right breast which had been treated with lumpectomy and 
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radiotherapy in July 2007. The patient was under regular re-
view by the oncologists and was subsequently given the all 
clear.
Eight months after left THR, the patient was referred by 
her family doctor with increasing pain and limping arising 
from left hip. After thorough clinical assessment, the patient 
underwent X-ray of the pelvis and baseline blood investiga-
tions along with C- reactive protein (CRP) and erythrocyte 
segmentation rate (ESR). The x-ray revealed extensive de-
struction of periacetabular bone in the left hemipelvis (Fig. 
2). The blood investigations were essentially normal apart 
from a CRP of 22 and alkaline phosphatase increased to 432 
(normal range 30-150)
An urgent isotope bone scan and computed tomography 
(CT) of her pelvis were performed. The three phase bone 
scan demonstrated intense uptake in the left acetabulum, 
superior pubic ramus and iliac crest region conﬁ  rming the 
presence of metastasis. It also revealed widespread bony 
metastasis involving the axial skeletal as well as head and 
neck region (Fig. 3). The CT scan of the pelvis conﬁ  rmed 
extensive destruction of the left iliac wing (Fig. 4). X-rays of 
pelvis taken few months after initial diagnosis showed rapid 
progression of the periacetabular bone loss and superior mi-
gration of the acetabular component. The femoral prosthesis 
did not show any evidence of osteolysis (Fig. 5).
The patient was referred back to her oncology team for 
further assessment and management. The widespread me-
tastases were conﬁ  rmed to be secondary to her breast carci-
noma and treated with palliative radiotherapy and hormone 
therapy.
 
Discussion
  
Infection, aseptic loosening and ischio-pubic osteolysis are 
the well documented causes of periprosthetic bone loss af-
Figure 1. X-ray pelvis following total hip replacement.
Figure 3. Radinucleotide bone scan conﬁ  rms 
increased uptake in left hemipelvis.
Figure 2. Eight month follow-up X-ray showing isolated 
periacetabular bone loss in left hip. Figure 4. CT scan showing periacetabular bone loss.
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ter joint replacement surgery [1, 3]. Metastatic inﬁ  ltration 
around a joint replacement is uncommon but has been an 
emerging concern in last two decades as the survival of pa-
tients following malignancy and longevity of joint replace-
ments has been increasing. Periprosthetic osteolysis can 
result in massive bone loss around the implant, leading to 
loosening of the components and periprosthetic fractures.
Occurrence of primary malignant tumors around 
prosthetic joint replacements has been more frequently 
reported than metastatic inﬁ  ltration [4, 5]. Thyroid, breast, 
lung, gastric, hepatocellular, prostate, Kidney and ovarian 
carcinomas and non-Hodgkin’s lymphoma are the primaries 
identiﬁ  ed so far leading to metastasis around hip replacement  
[2, 6-10].
The pathoetiology behind metastatic inﬁ  ltration around 
orthopaedic implants has been well described. An increased 
vascularity due to surgical trauma and the healing process 
leads to a predilection of metastatic deposition around joint 
replacement sites [11]. In the setting of a bony metastasis, 
periprosthetic osteolysis may be due to direct metastatic in-
ﬁ  ltration or an inﬂ  ammatory reaction to the metastatic de-
posit leading to necrosis of bone and thus loosening of com-
ponent [5].
Periprosthetic osteolysis due to metastatic inﬁ  ltration 
Figure 5. Judet view revealing rapid progression of osteolysis and migration of left acetabular component.
Table 1. Review of Reported Cases of Metastatic Inﬁ  ltration Around Hip Replacement From English Lan-
guage Literature
Case report Primary
Site of 
involvement
Duration since hip 
replacement
Treatment
Survival after 
detection
Dramis et al. 
2008
Renal Cell Carcinoma Proximal Femur 6 months Palliative 6 months
O’Shea et al. 
2006
Lung Adenocarcinoma Proximal Femur 60 months
Revision 
usncemented THR
6 weeks
Malignant 
Immunoblastic 
Lymphoma
Proximal Femur 156 months
Excision 
arthroplasty
20 weeks
Gastric Carcinoma Acetabulum 4 months
Girdlestone 
resection 
arthroplasty
10 weeks
Allain et al. 
1998
Lung Squamous cell 
carcinoma
Synovium around 
hip
60 months Revision THR 3 months
Schmidt et al. 
1996
Ovarian Carcinoma Proximal femur 21 months Palliative 10 months
Hepatocellular 
Carcinoma
Proximal femur 52 months Revision THR Not available
Donohoe et al. 
1987
Non-Hodgkin’s 
Lymphoma
Proximal femur Not Available Not available Not available
Kim et al. 
1986
Lung  
Adenocarcinoma
Proximal femur 8 months Hip disarticulation 11 months
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is reported more commonly around the femoral component 
than the acetabulum. Breast is the commonest site of 
carcinoma in female patients and despite which not many 
cases of periprosthetic metastatic involvement following hip 
replacement have been reported in literature. O’Shea et al. 
reported the ﬁ  rst case of isolated periacetabular metastatic 
involvement following THR in a patient with gastric 
carcinoma [9]. To our knowledge, this is the ﬁ  rst reported 
case of metastatic breast carcinoma presenting with early, 
isolated, extensive periacetabular bone loss following THR.
Schmidt et al. in their experience of two cases of 
metastatic, periprosthetic osteolysis have admitted that 
the delay in actual diagnostic etiology could lead to 
major physical and psychological trauma to patient. They 
recommended that apart from routine investigations, a tissue 
biopsy must be obtained before undertaking any revision 
procedure and intra-operative frozen section analysis of tissue 
should be obtained during the revision procedure to rule out 
malignancy as well as infection [7]. Importantly, it has been 
reported that the number of cases of periprosthetic osteolysis 
due to metastases has been initially incorrectly attributed to 
infection, thus delaying its appropriate management [4, 9, 
12].
As the number of cases reported in the literature is very 
few and infrequent, it is difﬁ  cult to draw a causal relation-
ship between the nature of the primary tumor and peripros-
thetic osteolysis. The time interval between detection of 
periprosthetic metastasis and a hip replacement has been 
variable with very few reported cases diagnosed within a 
year [2, 6-10]. Patient survival after detection of metastases 
around hip replacements has been reported to be poor.  It is 
therefore necessary to get a detailed history, thorough physi-
cal examination, routine as well as tumor speciﬁ  c blood tests 
along with a radio-nucleotide bone scan and CT in patients 
presenting with painful joint replacements. The early detec-
tion can improve the survival and quality of life in this group 
of patients.
Conclusion
Metastatic inﬁ  ltration along with septic and aseptic loos-
ening should be considered as a potential cause of early 
periprosthetic bone loss. Detailed history and physical ex-
amination along with radio-nucleotide bone scan, CT and 
recommended blood tests should form part of investigations 
in patient with periprosthetic bone loss. In cases with atypi-
cal presentation tissue diagnosis should be obtained either by 
biopsy or aspiration of the joint before revision procedure is 
considered.
Patients with a known history of malignancy should 
be screened with a pre-operative bone scan to rule out any 
metastatic inﬁ  ltration. This group of patients should be made 
aware about the possibility of metastatic inﬁ  ltration around 
joint replacement prosthesis and should have a regular fol-
low-up at short intervals to detect any early bone loss.
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